-
Cholangiocarcinoma.
Division of Gastroenterology and Hepatology, Center for the Basic Research in Digestive Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
PMID: 15887157 [PubMed - indexed for MEDLINE]
-
Cited by 9 PubMed Central articles
-
Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth.
Marzioni M, Invernizzi P, Candelaresi C, Maggioni M, Saccomanno S, Selmi C, Rychlicki C, Agostinelli L, Cassani B, Miozzo M, et al.
Dig Liver Dis. 2009 Jul; 41(7):523-33. Epub 2008 Oct 22.
[Dig Liver Dis. 2009]
-
Surgery for extrahepatic cholangiocarcinoma: predictors of survival.
Kloek JJ, Ten Kate FJ, Busch OR, Gouma DJ, Van Gulik TM.
HPB (Oxford). 2008; 10(3):190-5.
[HPB (Oxford). 2008]
-
ReviewControl of cholangiocyte adaptive responses by visceral hormones and neuropeptides.
Marzioni M, Fava G, Alvaro D, Alpini G, Benedetti A.
Clin Rev Allergy Immunol. 2009 Feb; 36(1):13-22.
[Clin Rev Allergy Immunol. 2009]
- » See all...